See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Requip, Requip XL
What is Ropinirole?
Ropinirole is an anti-Parkinson's agent used to treatment the signs and symptoms of idiopathic Parkinson's disease (PD). It is also indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
Read more...
370 patients in the community are taking or have taken Ropinirole.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Treat Parkinson's | 239 | 70% |
| Other | 50 | 14% |
| Stiffness/spasticity | 24 | 7% |
| General health | 6 | 1% |
| Restless Leg Syndrome | 5 | 1% |
| disease-related symptoms | 3 | <1% |
| Pain | 2 | <1% |
| Night-time leg spasms | 1 | <1% |
| Fasciculations | 1 | <1% |
| Anxiety | 1 | <1% |
| Muscle cramping, spasms | 1 | <1% |
| Freezing of gait | 1 | <1% |
| Pain, chronic | 1 | <1% |
| Numbness, tingling, pins & needles (paresthesia) | 1 | <1% |
| Constipation | 1 | <1% |
| Restless legs when trying to sleep | 1 | <1% |
| Fatigue | 1 | <1% |
| Mobility | 1 | <1% |
| Tremors | 1 | <1% |
| 0 mg day | 0 day | 0 mg none | 0.25 mg day | 0.5 mg day | 0.75 mg day | 1 mg day | 1 day | 1.25 mg day | 1.5 mg day | 2 mg day | 3 mg day | 4 mg day | 4 day | 4.5 mg day | 5 mg day | 6 mg day | 7 mg day | 7.5 mg day | 8 mg day | 9 mg day | 10 mg day | 10.25 mg day | 11 mg day | 12 mg day | 13 mg day | 14 mg day | 15 mg day | 16 mg day | 18 mg day | 20 mg day | 21 mg day | 22 mg day | 23 mg day | 24 mg day | 25 mg day | 32 mg day | 200 mg day | 300 mg day | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
10
|
1
|
1
|
10
|
12
|
3
|
22
|
1
|
1
|
5
|
19
|
22
|
17
|
1
|
3
|
4
|
34
|
3
|
1
|
11
|
20
|
6
|
1
|
1
|
25
|
3
|
2
|
17
|
7
|
4
|
2
|
4
|
1
|
1
|
5
|
1
|
1
|
1
|
1
|
||
How long current patients have been taking Ropinirole or how long patients were taking Ropinirole before stopping.
Results from 22 patient evaluations. See the overall results and all individual evaluations.
| Major | 39% | 7 |
|---|---|---|
| Moderate | 28% | 5 |
| Slight | 11% | 2 |
| None | 6% | 1 |
| Can't tell | 17% | 3 |
Treat Parkinson's
| Severe | 14% | 3 |
|---|---|---|
| Moderate | 41% | 9 |
| Mild | 23% | 5 |
| None | 23% | 5 |
Top reported side-effects include: daytime sleepinesss, nauesa, Fatigue
Summary results are based on 22 individual responses. For more information, see overall results for Adherence, Burden and Cost.